- Bloomberg•7 hours ago
Mylan NV engaged in a campaign to squash a rival to its EpiPen allergy treatment and artificially inflate the price of the drug to maintain a market monopoly, French drugmaker Sanofi said in a lawsuit ...
- GlobeNewswire•7 hours ago
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible ...
- TheStreet.com•7 hours ago
French multinational pharmaceutical company Sanofi on Monday filed a lawsuit against U.S. company Mylan.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||84.23 - 85.94|
|52 Week Range||62.50 - 86.05|
|PE Ratio (TTM)||23.36|
|Dividend & Yield||3.35 (3.72%)|
|1y Target Est||N/A|